Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups

[August 11, 2023]  TASHKENT (Reuters) - Uzbekistan began a trial on Friday over the deaths last year of 65 children linked to contaminated cough syrups, announcing for the first time a much higher death toll than before.

The Central Asian nation had previously reported only 20 deaths linked to the medicines, which were produced by India's Marion Biotech.

Among the 21 defendants - who are all Uzbek citizens - are former senior officials who were in charge of licensing imported medicines and executives of a private company that imported and distributed them, Uzbekistan's Supreme Court said in statement.

Charges against them include tax evasion, sale of substandard or counterfeit medicines, abuse of office, negligence, forgery, and bribery.

A cough medication is poured in this picture illustration taken October 19, 2022. REUTERS/Ajeng Dinar Ulfiana/Illustration/file photo

The Indian regulator has canceled the manufacturing license of Marion Biotech, which had exported the syrups to Uzbekistan, and arrested some of its employees.

In December, a legal representative of Marion Biotech said the company regretted the deaths.

(Reporting by Mukhammadsharif Mamatkulov; Writing by Olzhas Auyezov; Editing by Toby Chopra)

[© 2023 Thomson Reuters. All rights reserved.]This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.